Treatment of bullous pemphigoid with tetracyclines and topical corticosteroids

European Journal of Dermatology

Volumn 7, Issue 8, 1997, Pages 570-573

  Depaire Duclos, Florence ^a   Dandurand, Michel ^a   Basset Seguin, Nicole ^b   Guilhou, Jean Jacques ^b   Guillot, Bernard ^a  

^a DEPARTMENT OF NEUROLOGY   (France)

^b MONTPELLIER UNIVERSITY HOSPITAL   (France)

Author keywords

Bullous pemphigoid; Tetracyclines; Topical corticosteroids; Treatment

Indexed keywords

CORTICOSTEROID; TETRACYCLINE DERIVATIVE;

ADULT; AGED; ARTICLE; CANDIDIASIS; CLINICAL ARTICLE; DIARRHEA; FEMALE; HUMAN; HYPOGLYCEMIA; KIDNEY FAILURE; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; PEMPHIGOID; STOMACH PAIN; STOMACH ULCER; TOPICAL DRUG ADMINISTRATION;

EID: 0031468624     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Huilgol SC, Black MM. Management of the immunobullous disorders. Pemphigoid. Clin Exp Dermatol 1995; 20: 189-201.
2. Lever WF. Pemphigus. Medicine (Baltimore) 1953; 32: 1-123.
3. Savin JA. The events leading to the death of patients with pemphigus and pemphigoid. Br J Dermatol 1979; 101: 521-34.
4. Bernard P, Venot J, Rommel A, Bonnetblanc JM, Texier L. Pemphigoïde bulleuse: étude du pronostic. A propos de cinquante-sept observations. Sem Hôp Paris 1986; 62: 1229-32.
5. Venning VA, Wojnarowska F. Lack of predictive factors for the clinical course of bullous pemphigoid. J Am Acad Dermatol 1992; 26: 585-9.
6. Bernard P, Enginger V, Venot J, Bedane C, Bonnetblanc JM. Le pronostic vital de la pemphigoïde bulleuse: analyse d'une cohorte de 78 patients. Ann Dermatol Venerol 1994; 121 (suppl. 1): C4.
7. Roujeau JC, Enginger V, Lok C, Mhalla S, Devendeville A, Bonnetblanc JM, Deneux JP, Revuz J, Bernard P. Risque de rechute à long terme de la pemphigoïde bulleuse. Ann Dermatol Venereol 1995, 122 (suppl. I): C29.
8. Fox BJ, Odom RB, Findlay RF. Erythromycin therapy in bullous pemphigoid: possible anti-inflammatory effects. J Am Acad Dermatol 1982; 7: 504-10.
9. Bonnetblanc JM, Souyri N, Bernard P. Pemphigoïde et érythromycine. Ann Dermatol Venereol 1983; 110: 951.
10. Humbert P, Treffel P, Chapuis JF, Buchet S, Derancourt C, Agache P. The tetracyclines in dermatology. J Am Acad Dermatol 1991; 25: 691-7.
11. Humbert P, Renaud A, Millet J, Taillard C, Marchal F, Laurent R, Agache P. Evaluation of the effect of heparin and tetracycline on the cohesion of the dermal-epidermal junction. Acta Derm Venereol 1989; 69: 434-6.
12. Thornfeldt CR, Menkes AW. Bullous pemphigoid controlled by tetracycline. J Am Acad Dermatol 1987; 16: 305-10.
13. Pereyo NG, Davis LS. Generalized bullous pemphigoid controlled by tetracycline therapy alone. J Am Acad Dermatol 1995; 32: 138-9.
14. Miralles ES, Cabezon MN, Pozueta AL. Treatment of generalized bullous pemphigoid with oral tetracycline. Correspondence. J Am Acad Dermatol 1994; 30: 291.
15. Berk MA, Lorincz AL. The treatment of bullous pemphigoid with tetrocycline and niacinamide. A preliminary report. Arch Dermatol 1986; 122: 670-4.
16. Fivenson DP, Breneman CL, Rosen GB, Hersh CS, Cardone S, Mutasim D. Nicotinamide and tetracycline tnerapy of bullous pemphiqoid. Arch Dermatol 1994; 130: 753-8.
17. Kolbach DN, Remme JJ, Bos WH, Jonkman MF, De Jong MCJM, Pas HH, Van der Meer JB. Bullous pemphigoid successfully controlled by tetracycline and nicotinamide. Br J Dermatol 1995; 133: 88-90.
18. Thomas I, Khorenian S, Arbesfeld DM. Treatment of generalized bullous pemphigoid with oral tetracycline. J Am Acad Dermatol 1993; 28: 74-7.
19. Chosidow O, Saada V, Diquet D, Roujeau JC, Revuz J. Correlation between the pretreatment number or blisters and the time to control bullous pemphigoid with prednisone 1 mg/kg/day. Br J Dermatol 1992, 127: 185.
20. Westerhof W. Treatment of bullous pemphigoid with topical clobetasol propionate. J Am Acad Dermatol 1989; 20: 458-61.
21. Young P, Joly P, Sevrain-Verdier S, Thomine E, Delpech A, Le Corvaisier C, Balguerie X, Courville P, Tron F, Lauret P. Traitement de la pemphigoïde bulleuse par la corticothérapie locale. A propos de vingt-quatre cas. Ann Dermatol Venereol 1994; 121 (suppl. 1): C37.
22. Loche F, Bazex J, Giard A, Grolleau P, Marguery MC. Efficacy and tolerability of topical corticosteroid treatment in the initial phase of bullous pemphigoid: an open study of 13 cases. J Dermatol Treat 1995; 6: 69-72.
23. Paquet P, Richelle M, Lapiere CM. Bullous pemphigoid treated by topical corticosteroids. Acta Derm Venereol 1991; 71: 534-5.
24. Spuls PI, Brakman M, Westerhof W, Bos JD. Treatment of generalized bullous pemphigoid with topical corticosteroids. Acta Derm Venereol 1995; 75: 89.
25. Auger M, Bouscarat F, Picard-Dahan C, Descamps V, Grossin M, Crickx B, Belaich S. Traitement de la pemphigoide par dermocorticodes. Ann Dermatol Venereol 1995; 122 (suppl. 1): C28.
26. Brakman M, Westerhof W. Treatment of generalized bullous pemphigoid with oral tetracycline. J Am Acad Dermatol 1994; 30: 145-6.
27. Wright AL, Colver GB. Tetracyclines: how safe are they? Clin Exp Dermatol 1988; 13: 57-61.
28. Hornschuh B, Hamm H, Wever S, Hashimoto T, Schröber U, Bröcker E, Zillikens D. Treatment of 16 patients with bullous pemphigoid with oral tetracycline and niacinamide and topical clobetasol. J Am Acad Dermotol 1997; 36: 101-3.